STOCK TITAN

Eton Pharmaceuticals (ETON) COO discloses options and 128,985 performance RSUs

(Neutral)
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Eton Pharmaceuticals’ Chief Operating Officer Danka Radosavljevic filed an initial statement of beneficial ownership, detailing equity interests in Eton common stock and equity awards. Reported positions include multiple employee stock options with exercise prices ranging from $1.38 to $15.47 per share and expiration dates between 2027 and 2036, time-vested restricted stock units, and a sizeable performance-based award.

The performance-vested restricted stock unit grant covers 128,985 potential shares and vests in full only if Eton’s common stock closing price reaches or exceeds $72.36 for one trading day on or before July 31, 2029; otherwise, it is forfeited. The filing reflects holdings only and does not report any concurrent purchases or sales.

Positive

  • None.

Negative

  • None.
Insider Radosavljevic Danka
Role Chief Operating Officer
Type Security Shares Price Value
holding Employee Stock Option (Right to Buy) F1 -- -- --
holding Restricted Stock Units F3, F2 -- -- --
holding Restricted Stock Units F3, F4 -- -- --
holding Employee Stock Option (Right to Buy) F5 -- -- --
holding Employee Stock Option (Right to Buy) F6 -- -- --
holding Employee Stock Option (Right to Buy) F7 -- -- --
holding Employee Stock Option (Right to Buy) F8 -- -- --
holding Employee Stock Option (Right to Buy) F9 -- -- --
holding Employee Stock Option (Right to Buy) F10 -- -- --
holding Employee Stock Option (Right to Buy) F11 -- -- --
holding Employee Stock Option (Right to Buy) F12 -- -- --
holding Common Stock F13 -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Employee Stock Option (Right to Buy) — 314,784 shares (Direct); Restricted Stock Units — 27,233 shares (Direct); Common Stock — 151,458 shares (Direct)
Footnotes (13)
  1. F1. The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on January 12, 2030.
  2. F2. The restricted stock units vest in four equal annual installments beginning January 12, 2027, contingent upon the reporting person being employed by the issuer on the date(s) of vesting.
  3. F3. Each restricted stock unit represents a contingent right to receive one share of ETON Common Stock.
  4. F4. The restricted stock units vest in four equal annual installments beginning January 3, 2026, contingent upon the reporting person being employed by the issuer on the date(s) of vesting.
  5. F5. The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on January 3, 2029.
  6. F6. The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on March 18, 2029.
  7. F7. The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on February 13, 2028.
  8. F8. The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on August 15, 2027.
  9. F9. The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on February 20, 2027.
  10. F10. The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on May 3, 2025.
  11. F11. The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on March 12, 2024.
  12. F12. The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on July 24, 2021.
  13. F13. On July 31, 2026, the reporting person was granted 128,985 performance-vested restricted stock units granted under the Issuer's 2018 equity incentive plan. Each restricted stock unit represents the right to acquire one share of Issuer common stock. The award vests in full, and all restrictions lapse, immediately upon the closing price of the Issuer's common stock equaling or exceeding $72.36 per share for one trading day at any time prior to the third anniversary of the grant date. If this market condition is not satisfied prior to such date, the award will be forfeited in its entirety without consideration on July 31, 2029. The number of shares reported reflects the maximum and only number of shares issuable under the award; there is no target, threshold, or maximum range.
Performance RSUs 128,985 shares Performance-vested restricted stock units granted July 31, 2026
Performance hurdle price $72.36 per share Closing price required for performance RSUs to vest in full
Performance period end July 31, 2029 Deadline to satisfy market condition for performance RSUs
Option exercise price $4.42 per share Employee stock option over 92,993 underlying shares expiring February 12, 2034
Option exercise price $3.58 per share Employee stock option over 60,000 underlying shares expiring March 11, 2030
Highest option strike $15.47 per share Employee stock option over 31,508 underlying shares expiring January 11, 2036
Time-vested RSUs 20,039 shares Restricted stock units vesting in four equal annual installments beginning January 12, 2027
Additional RSUs 7,194 shares Restricted stock units vesting in four equal annual installments beginning January 3, 2026
Restricted Stock Units financial
"The restricted stock units vest in four equal annual installments beginning January 12, 2027"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
performance-vested restricted stock units financial
"the reporting person was granted 128,985 performance-vested restricted stock units granted under the Issuer's 2018 equity incentive plan"
equity incentive plan financial
"granted 128,985 performance-vested restricted stock units granted under the Issuer's 2018 equity incentive plan"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
market condition financial
"If this market condition is not satisfied prior to such date, the award will be forfeited in its entirety"
beneficial ownership financial
"filed an initial statement of beneficial ownership, detailing equity interests in Eton common stock"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

FAQ

What does ETON’s Form 3 filing for Danka Radosavljevic show?

The Form 3 shows COO Danka Radosavljevic’s initial beneficial ownership in Eton, including stock options, time-vested restricted stock units, and performance-vested restricted stock units tied to Eton’s common stock price.

How many performance-vested RSUs does ETON’s COO hold under this Form 3?

The COO holds 128,985 performance-vested restricted stock units, each representing one share of Eton common stock, that vest only if a specified market condition is satisfied before July 31, 2029.

What market condition applies to the 128,985 performance RSUs reported by ETON?

The award vests fully if Eton’s common stock closing price reaches or exceeds $72.36 per share for one trading day on or before July 31, 2029; otherwise, it is forfeited without consideration.

What stock option grants are disclosed for ETON’s COO in this Form 3?

Disclosed employee stock options include grants over 92,993 shares at an exercise price of $4.42, 60,000 shares at $3.58, and other tranches with exercise prices up to $15.47, all held directly.

How do the time-vested RSUs in ETON’s Form 3 vest for the COO?

Time-vested RSUs over 20,039 and 7,194 underlying shares vest in four equal annual installments beginning in 2026 and 2027, contingent on continued employment on each vesting date.

Does ETON’s Form 3 for Danka Radosavljevic report any stock purchases or sales?

No. The Form 3 lists existing holdings—common stock, options, and restricted stock units—but reports no buy or sell transactions, only positions as of the reporting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Radosavljevic Danka

(Last)(First)(Middle)
C/ ETON PHARMACEUTICALS, INC.
21925 W. FIELD PARKWAY, SUITE 235

(Street)
DEERPARK ILLINOIS 60010

(City)(State)(Zip)

UNITED STATES

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
07/31/2026
3. Issuer Name and Ticker or Trading Symbol
Eton Pharmaceuticals, Inc. [ ETON ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Operating Officer
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock22,473D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (Right to Buy) (1)01/11/2036Common Stock31,508$15.47D
Restricted Stock Units (2) (2)Common Stock20,039$0(3)D
Restricted Stock Units (4) (4)Common Stock7,194$0(3)D
Employee Stock Option (Right to Buy) (5)01/02/2035Common Stock14,317$13D
Employee Stock Option (Right to Buy) (6)03/17/2035Common Stock10,000$14.68D
Employee Stock Option (Right to Buy) (7)02/12/2034Common Stock92,993$4.42D
Employee Stock Option (Right to Buy) (8)08/14/2033Common Stock10,000$4.74D
Employee Stock Option (Right to Buy) (9)02/19/2033Common Stock42,224$3.47D
Employee Stock Option (Right to Buy) (10)05/02/2031Common Stock35,000$8.61D
Employee Stock Option (Right to Buy) (11)03/11/2030Common Stock60,000$3.58D
Employee Stock Option (Right to Buy) (12)07/23/2027Common Stock18,742$1.38D
Common Stock (13) (13)Common Stock128,985$0D
Explanation of Responses:
1. The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on January 12, 2030.
2. The restricted stock units vest in four equal annual installments beginning January 12, 2027, contingent upon the reporting person being employed by the issuer on the date(s) of vesting.
3. Each restricted stock unit represents a contingent right to receive one share of ETON Common Stock.
4. The restricted stock units vest in four equal annual installments beginning January 3, 2026, contingent upon the reporting person being employed by the issuer on the date(s) of vesting.
5. The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on January 3, 2029.
6. The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on March 18, 2029.
7. The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on February 13, 2028.
8. The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on August 15, 2027.
9. The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on February 20, 2027.
10. The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on May 3, 2025.
11. The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on March 12, 2024.
12. The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on July 24, 2021.
13. On July 31, 2026, the reporting person was granted 128,985 performance-vested restricted stock units granted under the Issuer's 2018 equity incentive plan. Each restricted stock unit represents the right to acquire one share of Issuer common stock. The award vests in full, and all restrictions lapse, immediately upon the closing price of the Issuer's common stock equaling or exceeding $72.36 per share for one trading day at any time prior to the third anniversary of the grant date. If this market condition is not satisfied prior to such date, the award will be forfeited in its entirety without consideration on July 31, 2029. The number of shares reported reflects the maximum and only number of shares issuable under the award; there is no target, threshold, or maximum range.
Remarks:
The reporting person has authorized and designated the named person to file this Form 3 on the reporting person's behalf for indefinite duration.
/s/ Judith Matthews08/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)